Sofosbuvir plus Peginterferon plus Ribavirin for 12 Weeks in Genotype 3 HCV Infected Patients and Treatment-Experienced Cirrhotic Patients with Genotype 2 HCV Who Did Not Achieve SVR after 16 or 24 Weeks of Sofosbuvir plus RibavirinKosh Agarwal,Michael Schultz,Stephen Pianko, Leslie Bank,Jane Collier,Jacob George,Matthew Priest,Stephen D. Ryder,Blaire E. Burman,Kuldeep Cheent,Matthew Cramp,Daniel M. Forton,Barbara A. Leggett,Gerry C. MacQuillan,Alnoor Ramji,Paul Richardson,Michael J. Ryan, Nigel Stace,Amany Zekry, Donald L. Zogg,Eleanor Barnes,Diana M. Brainard,Benedetta Massetto,Frances Chen,John G. McHutchison,Mani Subramanian,Eric M. Yoshida,Graham R. FosterHEPATOLOGY（2016）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
